Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Intas Pharmaceuticals

Tracked across 5 events · 34 articles · First seen Jun 09, 2026 · Last active Sep 22, 2026

Sentiment
-17
Attention
6
Events
5
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -30
Domestic
Impact: Intas Pharmaceuticals>>> is a generic drugmaker in India>>> producing platinum-based chemotherapy, facing challenges due to platinum shortages and price caps.
Jun 09, 2026 · 9 articles
4 -30
Regulatory
Impact: Intas Pharmaceuticals is the parent company of Intas Pharmaceuticals, which lost the patent challenge, delaying its generic Sacubitril/valsartan launch in the UK and potentially affecting its market strategy.
Aug 13, 2026 · 6 articles
2 -15
Regulatory
Impact: Separately had a Class II recall for subpotent levothyroxine tablets, highlighting broader quality issues in thyroid medications.
Aug 25, 2026 · 6 articles
2 -5
Business
Biocon, an Indian biopharmaceutical company, signed a partnership agreement with Bahiafarma, a public pharmaceutical laboratory of the State of Bahia, and Bionovis, a Brazilian biotechnology company, to manufacture and commercialize Pertuzumab, a monoclonal antibody for…
Impact: As a competitor in biosimilars, Intas may face increased competition in Brazil's public market.
Sep 08, 2026 · 6 articles
4 -5
Regulatory
Biopharmaceutical, a wholly-owned subsidiary of Biocon, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Union — European Medicines Agency issued a positive opinion recommending marketing authorisation for its Pertuzumab…
Impact: Indian pharmaceutical company mentioned among domestic marketers of Pertuzumab biosimilar alternatives in India.
Sep 21, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Intas Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.